MDC-2050

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMDC-2050
Drug Alias NameMDC-2050
ClassificationOther
Mechanisms of ActionCannabinoid receptor modulators
TargetsCannabinoid receptor
Therapy Area/IndicationsCarcinoma, Squamous Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedC Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesMedC Biopharma Corp
Inactive CompaniesN/A
Active IndicationsCarcinoma, Squamous Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A